Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael W. Rogers Insider Profile
4 Followers
Michael W. Rogers, CFO at Acorda Therapeutics, holds 96.03K shares in Akebia Therapeutics (Ticker: AKBA), holds 119.17K shares in EyePoint Pharmaceuticals (Ticker: EYPT), holds 0.00 shares in Keryx Biopharma (Ticker: KERX).
Michael W. Rogers has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Michael W. Rogers holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 16, 2018 - Nov 16, 2019
Return:-36.40%
The most profitable trade made by Michael W. Rogers
Michael W. Rogers's Trading History
Acorda Therapeutics
Dec 03, 2015
CFO
Uninformative Sell
36.68K
$35.79K
Keryx Biopharma
Dec 13, 2018
―
Uninformative Sell
―
$0.00
Aadi Bioscience
―
Chief Financial and Chief Business Officer
―
―
Akebia Therapeutics
Jun 08, 2023
Director
Uninformative Buy
―
$134.44K
Aravive
―
―
―
―
EyePoint Pharmaceuticals
Jun 24, 2019
Director
Uninformative Buy
―
$1.41M
BG Medicine
―
EVP, CFO & Treas
―
$0.00
List of latest transactions for each holding click on a transaction to see Michael W. Rogers's performance on stock
You May Also Like
Michael W. Rogers insider profile FAQ
What is the percentage of profitable transactions made by Michael W. Rogers?
The percentage of profitable transactions made by Michael W. Rogers is ―.
What is the average return per transaction made by Michael W. Rogers?
The average return per transaction made by Michael W. Rogers is ―.
What stocks does Michael W. Rogers hold?
Michael W. Rogers holds: ACORQ, KERX, AADI, AKBA, ARAV, EYPT, BGMD stocks.
What was Michael W. Rogers’s latest transaction?
Michael W. Rogers latest transaction was an Uninformative Buy of ―.
What was Michael W. Rogers's most profitable transaction?
Michael W. Rogers’s most profitable transaction was an Informative Buy of EYPT stock on November 16, 2018. The return on the trade was -36.40%.
What is Michael W. Rogers's role in Acorda Therapeutics?
Michael W. Rogers's role in Acorda Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.